3010 Phase, randomized trial (CheckMate 057) of nivolumab...

European Journal of Cancer 2015 / 09 Vol. 51

3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs)

Horn, L., Brahmer, J., Reck, M., Borghaei, H., Spigel, D.R., Steins, M., Ready, N.E., Chow, L.Q., Vokes, E.E., Felip, E., Holgado, E., Barlesi, F., Kohlhäufl, M.J., Burgio, M.A., Fayette, J., Gettinge
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(16)31655-0
Date:
September, 2015
File:
PDF, 60 KB
english, 2015
Conversion to is in progress
Conversion to is failed